Patients with tuberous sclerosis have fibroblasts with normal limits for growth characteristics and sensitivities to DNA alkylating agents.
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002648:Child; D004260:DNA Repair / Q000187:drug effects; D005020:Ethyl Methanesulfonate / Q000494:pharmacology; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects; D006801:Humans; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology; D012867:Skin / Q000166:cytology*; D014402:Tuberous Sclerosis / Q000473:pathology*
D008937:Mitomycins; D008769:Methylnitronitrosoguanidine; D016685:Mitomycin; D015112:4-Nitroquinoline-1-oxide; D005020:Ethyl Methanesulfonate